The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes Approval based on the TN-10 study, demonstrating Tzield’s ability to delay the ...

While it has long been known that type 1 diabetes runs in families, experts are less certain about what actually starts the autoimmune attack that defines the disease. Most people with type 1 diabetes ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on each patient’s clinical condition when determining initial treatment, ...

Cour Pharmaceuticals, the Chicago-based clinical-stage biotechnology company, says its first patient has been dosed in the phase 1b/2a clinical trial of a treatment that it hopes will address ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...

Vienna — A panel of experts from the European Association for the Study of Diabetes (EASD) has recommended general population screening for early-stage type 1 diabetes (T1D) beginning at age 2-4 years ...